 SAN DIEGO--BUSINESS WIRE--Acadia Pharmaceuticals Inc. Nasdaq: ACAD today announced that Elena Ridloff, Executive Vice President and Chief Financial Officer CFO, will be leaving the company effective September 10, 2021 to join another biopharmaceutical company. Mark Schneyer, Senior Vice President, Business Development and Chief Business Officer, will serve as Acadias interim Chief Financial Officer. The company is conducting a formal search for a new CFO. On behalf of all of us at Acadi 